The Difficulty Treating Colon Cancer

The Difficulty Treating Colon Cancer

  • By :
  • Category : Uncategorized
  • Comment : 0

One of the most aggressive and worst types of cancer is neuroendocrine carcinoma of colon. The worst thing about this is that more often than not it is detected at the advanced stages where is it very difficult to do anything about it.

As the effects of neuroendocrine colon cancer take form only at very advanced stages, the survival rate of the patient diminishes. Existing tumors are malignant and are usually detected with distant metastases. Most recent surveys show that reports tell us that most of the cases of neuroendocrine cancer ends in death.

Although the possibilities of neuroendocrine carcinoma in colon are extremely unlikely, if one has the misfortune to become affected the health of the patient becomes worse than those who are suffering from adenocarcinoma.

Research reveals that the final results of this form of cancer stay the same with age, sex or tumor location. Though neuroendocrine colon carcinoma will depend heavily on the tumor’s stage. Normal trends have revealed that people in stage 1 and 2 of cancer will generally not experience neuroendocrine colon cancer. But alternately in the majority of cases when the tumor is in stage 3 or 4, it is a laborious and tough job to treat the neuroendocrine colon carcinoma.

It is unfortunate that medical science has few techniques to help patients with this cancer. A more common technique that the doctors often use is immunohistochemical staining methods. This method helps doctors in dealing with the critical nature of the neuroendocrine colon cancer and helps to determine the suitable medication and a way to treat it. Immunohistochemical staining methods is specifically used for neuroendocrine markers. It involves the staining the tumor with the antibody A-80 which helps to identify the quantum of neuroendocrine differentiation and nature of the damage on the health of the patient.

Neuroendocrine colon carcinoma is difficult to treat and in a case study in which several patients stuffered from this disease were extensively examined it was observed that the overall survival rate for this disease was only about seven months. While in a predominant stage, the rates were as less as five months. Most cases were originally seen as carcinoids but later they developed in to neuroendocrine colon carcinoma. Neuroendocrine colon cancer has a poor prognosis and surgery may not be a successful treatment so, even surgery does not even cure the patient. Therefore it becomes necessary to detect this disease as soon as possible and provide proper medication for it.


Leave a Reply

Your email address will not be published. Required fields are marked *